Vasoactive Intestinal Peptide Receptor 2 (VIPR2) Peptid
-
- Target Alle VIPR2 Produkte
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
- Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Verwendungszweck
- VPAC2/VIPR2 (extracellular) Negative Control Antigen
- Sequenz
- CRFHLEIQEE ETK, correspond ing to amino acid residues 25-37 of human VPAC2 (Accession P41587).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-VPAC2 (VIPR2) (extracellular) Antibody (ABIN7043877, ABIN7045331 and ABIN7045332). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 2 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Konzentration
- 0.4 mg/mL
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-